BMY

Q: What is the price of Bristol-Myers Squibb (BMY) today?

The current price of Bristol-Myers Squibb (BMY) is $ 58.08, representing a 20.08% gain over the past year. The stock began the year trading around $ 53.94 and is currently priced at $ 58.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Bristol-Myers Squibb (BMY) pay dividends?

In the last year, Bristol-Myers Squibb (BMY) distributed dividends in the month of February, totaling $ 0.63. The Dividend Yield for the last 12 months is 4.23%.

Bristol-Myers Squibb Company

Price

$ 58.08

return (12m)

20.08%

p/e

16.98

p/bv

-3.52

DIVIDEND YIELD

4.23%

BMY price

BMY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BMY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.68%

3 months

4.13%

1 year

20.08%

2 years

34.08%

5 years

9.41%

10 years

20.19%

Fundamentals BMY

review the fundamentals of Bristol-Myers Squibb shares

P/E

16.98

Sector: -3.96 Industry: -3.96

P/S (PSR)

2.48

Sector: -3.88 Industry: -3.88

P/BV

-3.52

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

4.23%

Sector: - Industry: -

ROA

63.73%

Sector: -61.39% Industry: -61.39%

ROE

-20.72%

Sector: -60.71% Industry: -60.71%

ROIC

19.56%

Sector: -1,194.93% Industry: -1,194.93%

NET MARGIN

14.64%

Sector: -39.39% Industry: -39.39%

GROSS MARGIN

71.08%

Sector: 38.09% Industry: 38.09%

OPERATING MARGIN

28.47%

Sector: -39.58% Industry: -39.58%

EV/EBITDA

7.94

Sector: -3.80 Industry: -3.80

EV/EBIT

10.67

Sector: -4.02 Industry: -4.02

PRICE-TO-ASSETS

10.82

Sector: 1.38 Industry: 1.38

BVPS

-16.72

Sector: 1.89 Industry: 1.89

EPS

3.46

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

-3.08

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

4.08

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.77%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.17%

Sector: - Industry: -

Fundamentals BMY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.88	7.40	33.81%	2.14%	$ 586.59 B	28.46%
PFE	20.06	1.67	8.35%	6.28%	$ 155.85 B	12.42%
ABBV	89.02	0.00	0.00%	3.12%	$ 376.19 B	6.91%
NVO	10.61	5.46	51.50%	4.98%	$ 166.18 B	33.05%
MRK	16.72	0.00	0.00%	2.70%	$ 305.21 B	28.08%
AZN	31.27	6.56	20.99%	1.55%	$ 319.77 B	17.41%
GILD	20.77	7.81	37.62%	2.24%	$ 176.72 B	28.90%
ZTS	19.59	15.72	80.25%	1.70%	$ 52.37 B	28.23%
REGN	17.51	2.52	14.41%	0.47%	$ 78.86 B	31.41%
HALO	24.94	161.91	649.21%	0.00%	$ 7.90 B	22.69%
AMGN	24.97	22.24	89.06%	2.70%	$ 192.51 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.42	6.02	21.18%	0.00%	$ 112.36 B	32.94%
CAH	30.78	-18.95	-61.56%	0.94%	$ 51.16 B	0.68%
HRMY	10.31	1.88	18.24%	0.00%	$ 1.64 B	18.27%
ADMA	16.29	5.01	30.78%	0.00%	$ 2.39 B	28.80%
BIIB	20.21	1.43	7.08%	0.00%	$ 26.12 B	13.07%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

BMY Historical Dividends

current DY: 4.23%

5-year average DY: 4.23%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/02/2026	05/01/2026	0,63000000
Dividends	01/02/2026	02/02/2026	0,63000000
Dividends	10/03/2025	11/03/2025	0,62000000
Dividends	07/03/2025	08/01/2025	0,62000000
Dividends	04/04/2025	05/01/2025	0,62000000
Dividends	01/03/2025	02/03/2025	0,62000000
Dividends	10/04/2024	11/01/2024	0,60000000
Dividends	07/05/2024	08/01/2024	0,60000000
Dividends	04/05/2024	05/01/2024	0,60000000
Dividends	01/05/2024	02/01/2024	0,60000000
Dividends	10/06/2023	11/01/2023	0,57000000
Dividends	07/07/2023	08/01/2023	0,57000000
Dividends	04/10/2023	05/01/2023	0,57000000
Dividends	01/06/2023	02/01/2023	0,57000000
Dividends	10/07/2022	11/01/2022	0,54000000
Dividends	07/01/2022	08/01/2022	0,54000000
Dividends	04/01/2022	05/02/2022	0,54000000
Dividends	01/07/2022	02/01/2022	0,54000000
Dividends	10/01/2021	11/01/2021	0,49000000
Dividends	07/02/2021	08/02/2021	0,49000000
Dividends	04/01/2021	05/03/2021	0,49000000
Dividends	01/04/2021	02/01/2021	0,49000000
Dividends	10/02/2020	11/02/2020	0,45000000
Dividends	07/06/2020	08/03/2020	0,45000000
Dividends	04/03/2020	05/01/2020	0,45000000
Dividends	01/03/2020	02/03/2020	0,45000000
Dividends	10/04/2019	11/01/2019	0,41000000
Dividends	07/05/2019	08/01/2019	0,41000000
Dividends	04/05/2019	05/01/2019	0,41000000
Dividends	01/04/2019	02/01/2019	0,41000000
Dividends	10/05/2018	11/01/2018	0,40000000
Dividends	07/06/2018	08/01/2018	0,40000000
Dividends	04/06/2018	05/01/2018	0,40000000
Dividends	01/05/2018	02/01/2018	0,40000000
Dividends	10/06/2017	11/01/2017	0,39000000
Dividends	07/07/2017	08/01/2017	0,39000000
Dividends	04/07/2017	05/01/2017	0,39000000
Dividends	01/06/2017	02/01/2017	0,39000000
Dividends	10/07/2016	11/01/2016	0,38000000
Dividends	07/01/2016	08/01/2016	0,38000000
Dividends	04/01/2016	05/02/2016	0,38000000
Dividends	01/04/2016	02/01/2016	0,38000000
Dividends	10/02/2015	11/02/2015	0,37000000
Dividends	07/06/2015	08/03/2015	0,37000000
Dividends	04/06/2015	05/01/2015	0,37000000
Dividends	01/02/2015	02/02/2015	0,37000000
Dividends	10/03/2014	11/03/2014	0,36000000
Dividends	07/03/2014	08/01/2014	0,36000000
Dividends	04/04/2014	05/01/2014	0,36000000
Dividends	01/03/2014	02/03/2014	0,36000000
Dividends	10/04/2013	11/01/2013	0,35000000
Dividends	07/05/2013	08/01/2013	0,35000000
Dividends	04/05/2013	05/01/2013	0,35000000
Dividends	01/04/2013	02/01/2013	0,35000000
Dividends	10/05/2012	11/01/2012	0,34000000
Dividends	07/06/2012	08/01/2012	0,34000000
Dividends	04/05/2012	05/01/2012	0,34000000
Dividends	01/06/2012	02/01/2012	0,34000000
Dividends	10/11/2011	11/01/2011	0,33000000
Dividends	07/01/2011	08/01/2011	0,33000000
Dividends	04/01/2011	05/02/2011	0,33000000
Dividends	01/07/2011	02/01/2011	0,33000000
Dividends	10/01/2010	11/01/2010	0,32000000
Dividends	07/02/2010	08/02/2010	0,32000000
Dividends	04/04/2010	05/03/2010	0,32000000
Dividends	01/04/2010	02/01/2010	0,32000000
Dividends	10/02/2009	11/02/2009	0,31000000
Dividends	07/06/2009	08/03/2009	0,31000000
Dividends	04/03/2009	05/01/2009	0,31000000
Dividends	01/02/2009	02/02/2009	0,31000000
Dividends	10/03/2008	11/03/2008	0,31000000
Dividends	07/07/2008	08/01/2008	0,31000000
Dividends	04/04/2008	05/01/2008	0,31000000
Dividends	01/04/2008	02/01/2008	0,31000000
Dividends	10/05/2007	11/01/2007	0,28000000
Dividends	07/06/2007	08/01/2007	0,28000000
Dividends	04/06/2007	05/01/2007	0,28000000
Dividends	01/05/2007	02/01/2007	0,28000000
Dividends	10/06/2006	11/01/2006	0,28000000
Dividends	07/07/2006	08/01/2006	0,28000000
Dividends	04/07/2006	05/01/2006	0,28000000
Dividends	01/06/2006	02/01/2006	0,28000000
Dividends	10/07/2005	11/01/2005	0,28000000
Dividends	07/01/2005	08/01/2005	0,28000000
Dividends	04/01/2005	05/02/2005	0,28000000
Dividends	01/07/2005	02/01/2005	0,28000000
Dividends	10/01/2004	11/01/2004	0,28000000
Dividends	07/02/2004	08/02/2004	0,28000000
Dividends	04/02/2004	05/03/2004	0,28000000
Dividends	01/02/2004	02/02/2004	0,28000000
Dividends	10/03/2003	11/03/2003	0,28000000
Dividends	07/03/2003	08/01/2003	0,28000000
Dividends	04/04/2003	05/01/2003	0,28000000
Dividends	01/03/2003	02/01/2003	0,28000000
Dividends	10/04/2002	11/01/2002	0,28000000
Dividends	07/05/2002	08/01/2002	0,28000000
Dividends	04/05/2002	05/01/2002	0,28000000
Dividends	01/04/2002	02/01/2002	0,28000000
Dividends	10/05/2001	11/01/2001	0,27500000
Dividends	07/06/2001	08/01/2001	0,27500000
Dividends	04/06/2001	05/01/2001	0,27500000
Dividends	01/05/2001	02/01/2001	0,27500000
Dividends	10/06/2000	11/01/2000	0,24500000
Dividends	07/07/2000	08/01/2000	0,24500000
Dividends	04/07/2000	05/01/2000	0,24500000
Dividends	01/07/2000	02/01/2000	0,24500000
Dividends	10/01/1999	11/01/1999	0,21500000
Dividends	07/02/1999	08/01/1999	0,22590000
Dividends	04/02/1999	05/01/1999	0,21500000
Dividends	01/08/1999	02/01/1999	0,21500000
Dividends	10/02/1998	11/01/1998	0,20490000
Dividends	07/03/1998	08/01/1998	0,20490000
Dividends	04/03/1998	05/01/1998	0,20490000
Dividends	01/02/1998	02/01/1998	0,20490000
Dividends	10/03/1997	11/01/1997	0,19960000
Dividends	07/03/1997	08/01/1997	0,19960000
Dividends	04/04/1997	05/01/1997	0,19960000
Dividends	01/03/1997	02/01/1997	0,19962500
Dividends	10/04/1996	11/01/1996	0,19700000
Dividends	07/05/1996	08/01/1996	0,19700000
Dividends	04/05/1996	05/01/1996	0,19700000
Dividends	01/05/1996	02/01/1996	0,19700000
Dividends	10/06/1995	11/01/1995	0,19437500
Dividends	07/07/1995	08/01/1995	0,19437500
Dividends	04/07/1995	05/01/1995	0,19437500
Dividends	01/06/1995	02/01/1995	0,19437500
Dividends	10/07/1994	11/01/1994	0,19175000
Dividends	07/01/1994	08/01/1994	0,19175000
Dividends	04/01/1994	05/01/1994	0,19175000
Dividends	01/07/1994	02/01/1994	0,19175000
Dividends	10/01/1993	11/01/1993	0,18912500
Dividends	07/02/1993	08/01/1993	0,18912500
Dividends	04/02/1993	05/01/1993	0,18912500
Dividends	01/08/1993	02/01/1993	0,18912500
Dividends	10/02/1992	11/01/1992	0,18125000
Dividends	07/03/1992	08/01/1992	0,18125000
Dividends	04/03/1992	05/01/1992	0,18125000
Dividends	01/03/1992	02/01/1992	0,18125000
Dividends	10/04/1991	11/01/1991	0,15760000
Dividends	07/05/1991	08/01/1991	0,15760000
Dividends	04/05/1991	05/01/1991	0,15760000
Dividends	01/04/1991	02/01/1991	0,15760000
Dividends	10/05/1990	11/01/1990	0,13920000
Dividends	07/06/1990	08/01/1990	0,13920000
Dividends	04/06/1990	05/01/1990	0,13920000

ABOUT Bristol-Myers Squibb

Bristol-Myers Squibb Company

Average Investor10 user rating

4.0 (78 people)

United States

93 years

Founded: 1933

1952

Time since IPO - 74 years

30.250

Employees

Bristol-Myers Squibb Company operates in the Healthcare sector, within the Biopharmaceutical industry. Founded in 1887, the company develops, manufactures, and commercializes innovative prescription medicines globally.

Its portfolio is concentrated in high-value therapeutic areas:

Oncology.
Immunology.
Hematology.
Cardiovascular diseases.
Neuroscience.

Flagship products include Opdivo and Yervoy in oncology, as well as Eliquis for the prevention of stroke and other thromboembolic conditions.

The company operates internationally, with the United States representing a core revenue market. Bristol-Myers Squibb invests heavily in research and development and maintains partnerships with biotechnology companies and research institutions to expand its clinical pipeline.

Performance is influenced by patent exclusivity cycles, regulatory approvals, pricing policy, competition from generics and biosimilars, and R&D execution.

Bristol-Myers Squibb shares trade on the New York Stock Exchange (NYSE) under the ticker BMY.

History and Development

The company was founded in 1887 by William McLaren Bristol and John Ripley Myers. It expanded throughout the twentieth century, strengthening its presence in specialty pharmaceuticals.

A defining milestone occurred in 1989 with the merger between Bristol-Myers and Squibb Corporation, creating a global biopharmaceutical leader.

In recent years, the company has focused on expanding its pipeline through acquisitions, advancing cardiovascular and oncology therapies, and investing in precision medicine and next-generation biologics, reinforcing its long-term positioning in innovative drug development.

Additional Information

Bristol-Myers Squibb Company (United States) is listed on the NYSE and has a market capitalization of $119.74 Billions, with shareholders equity totaling $-34.04 Billions.

The company employs approximately 30.250 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Bristol-Myers Squibb Company reported $48.19 Billions in revenue, generating net income of $7.05 Billions.

Key financial metrics include a P/E ratio of 16.98, a price-to-book (P/B) ratio of -3.52, and a trailing twelve-month dividend yield of 4.23%.

The company trades under the ticker BMY.

Market cap

$ 119.74 Billions

Net worth

$ -34.04 Billions

$ -34,042,000,000.00

Assets

$ 11.07 Billions

$ 11,069,000,000.00

Total Shares Outstanding

2.04 Billions

2,036,000,000

Average Daily Trading Volume

$ 13.43 Millions

$ 13,434,586.00

Sector

Health Care

Industry

Biotechnology

BMY

revenue by Business Segment Bristol-Myers Squibb

Revenue by Region Bristol-Myers Squibb

BMY revenue and profits

Financial Results BMY

DRAG THE FRAME TO SEE MORE DATA

BMY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 862.96 25,04% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 214.95 61,92% (12M)

P/E

30.78

0.94%

ROE

-61.56%

P/BV

-18.95

JNJ - Johnson & Johnson

$ 240.16 60,69% (12M)

P/E

21.88

2.14%

ROE

33.81%

P/BV

7.40

PFE - Pfizer

$ 27.11 29,58% (12M)

P/E

20.06

6.28%

ROE

8.35%

P/BV

1.67

ABBV - AbbVie

$ 210.26 23,84% (12M)

P/E

89.02

3.12%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 119.96 58,59% (12M)

P/E

16.72

2.70%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 204.64 55,33% (12M)

P/E

31.27

1.55%

ROE

20.99%

P/BV

6.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 862.96 25,04% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 214.95 61,92% (12 M)

P/L

30.78

0.94%

ROE

-61.56%

P/VP

-18.95

JNJ - Johnson & Johnson

$ 240.16 60,69% (12 M)

P/L

21.88

2.14%

ROE

33.81%

P/VP

7.40

PFE - Pfizer

$ 27.11 29,58% (12 M)

P/L

20.06

6.28%

ROE

8.35%

P/VP

1.67

ABBV - AbbVie

$ 210.26 23,84% (12 M)

P/L

89.02

3.12%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 119.96 58,59% (12 M)

P/L

16.72

2.70%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 204.64 55,33% (12 M)

P/L

31.27

1.55%

ROE

20.99%

P/VP

6.56

Frequently Asked Questions

What is the price of Bristol-Myers Squibb (BMY) today?

The current price of Bristol-Myers Squibb (BMY) is $ 58.08, representing a 20.08% gain over the past year. The stock began the year trading around $ 53.94 and is currently priced at $ 58.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Bristol-Myers Squibb (BMY) pay dividends?

In the last year, Bristol-Myers Squibb (BMY) distributed dividends in the month of February, totaling $ 0.63. The Dividend Yield for the last 12 months is 4.23%.

Is Bristol-Myers Squibb (BMY) a good investment?

Bristol-Myers Squibb (BMY) is currently trading at $ 58.08 with a P/E ratio of 16.98%. This represents a 932% premium compared to its historical average P/E. Over the past year, the stock has gained 20.08 and paid $ 0.63 in dividends, resulting in a dividend yield of 4.23%. The total shareholder return over the same period was 20.08%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Bristol-Myers Squibb (BMY) stock?

You can buy Bristol-Myers Squibb (BMY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BMY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Bristol-Myers Squibb (BMY) yield today?

Over the past month, Bristol-Myers Squibb (BMY) has returned -0.68% — 20.08% over the past year, and 9.41% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 2.49 per share in dividends, resulting in a dividend yield of 4.23%.

If you were to purchase 100 shares of Bristol-Myers Squibb (BMY) today at the current price of $ 58.08 your total investment would be $ 5,808.00.

Based on historical performance, the investment would have grown to approximately:

$ 6,974.25 after 1 year
$ 6,354.53 after 5 years
$ 6,980.64 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BMY

Bristol-Myers Squibb Company

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BMY

review the fundamentals of Bristol-Myers Squibb shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 4.23%

5-year average DY: 4.23%

type

Ex - Dividend Date

payment date

value

ABOUT Bristol-Myers Squibb

Bristol-Myers Squibb Company

United States

93 years

1952

30.250

History and Development

Additional Information

PROFIT X PRICE BMY

Financial Results BMY

BMY cash flow

Asset, Revenue and Profit Growth - BMY

BMY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions